Published in J Psychopharmacol on February 15, 2016
Clinical applications of hallucinogens: A review. Exp Clin Psychopharmacol (2016) 0.78
Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. Int J Neuropsychopharmacol (2016) 0.75
Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization. Front Pharmacol (2017) 0.75
Modular Approach to pseudo-Neoclerodanes as Designer κ-Opioid Ligands. Org Lett (2017) 0.75
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A (2002) 4.34
Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend (2006) 1.52
Interactions between kappa opioid agonists and cocaine. Preclinical studies. Ann N Y Acad Sci (2000) 1.50
Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.). J Ethnopharmacol (1983) 1.49
Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor. Trends Pharmacol Sci (2003) 1.42
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacol Rev (2011) 1.26
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cell Mol Life Sci (2011) 1.25
Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sci (2005) 1.25
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug Alcohol Depend (2010) 1.20
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates. Synapse (2005) 1.13
Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug Alcohol Depend (2010) 1.12
Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats. Pharmacol Biochem Behav (2009) 1.11
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans. Biol Psychiatry (2012) 1.04
Kappa opioids and the modulation of pain. Psychopharmacology (Berl) (2010) 1.03
The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man. Br J Pharmacol (1997) 1.00
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology (Berl) (2012) 0.97
Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. Eur J Pharm Biopharm (2009) 0.96
Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Subst Abuse Rehabil (2011) 0.94
Acute and post-acute behavioral and psychological effects of salvinorin A in humans. Psychopharmacology (Berl) (2011) 0.91
Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace. Adolesc Psychiatry (Hilversum) (2013) 0.89
Use of Salvia divinorum in a nationally representative sample. Am J Drug Alcohol Abuse (2011) 0.82
Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans. Int J Neuropsychopharmacol (2015) 0.82
The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. J Psychopharmacol (2015) 0.81
LC-MS/MS quantification of salvinorin A from biological fluids. Anal Methods (2013) 0.77